Brief: Pharming Group Hikes FY Revenue Guidance To $365-375 Mln
06/11/2025 06:24
Nov 6 (Reuters) - Pharming Group NV PHAR.AS: PHARMING GROUP REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS WITH SIGNIFICANT GROWTH IN REVENUE, PROFITABILITY AND CASH FLOW TOTAL Q3 2025 REVENUES INCREASED BY 30% TO US$97.3 MILLION Q3 GENERATED US$32.0 MILLION IN CASH FLOW FROM OPERATIONS 2025 TOTAL REVENUE GUIDANCE RAISED TO US$365 - US$375 MILLION Q3 PROFIT FOR PERIOD $7.5 MILLION Source text: ID:nGNXcgMhmZ Further company coverage: PHAR.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))